MTOR and renal cell carcinoma: Sato et al. 8 performed whole-genome, whole-exome, and RNA sequencing of more than 100 patients with RCC and found that multiple PI3K/Akt/mTOR pathway-related mutations were present, in addition to the common VHL gene mutation.